Nifedipine increases cytochrome P4502C expression and endothelium-derived hyperpolarizing factor-mediated responses in coronary arteries

Hypertension

Volumn 36, Issue 2, 2000, Pages 270-275

  Fisslthaler, Beate ^a   Hinsch, Nora ^a   Chataigneau, Thierry ^a   Popp, Rüdiger ^a   Kiss, Ladislau ^b   Busse, Rudi ^a   Fleming, Ingrid ^a  

^a UNIVERSITY HOSPITAL FRANKFURT   (Germany)

^b JUSTUS LIEBIG UNIVERSITY   (Germany)

Author keywords

Arteries; Cytochrome P450; Endothelium derived hyperpolarizing factor; Nifedipine; Potassium channels

Indexed keywords

CYTOCHROME P450 2C9; ENDOTHELIUM DERIVED HYPERPOLARIZING FACTOR; NIFEDIPINE;

ARTICLE; CONTROLLED STUDY; DRUG EFFECT; ENZYME INDUCTION; GENE ISOLATION; GENE SEQUENCE; HUMAN; HUMAN CELL; HYPERPOLARIZATION; MUSCLE CELL; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; RECEPTOR UPREGULATION; VASCULAR SMOOTH MUSCLE; VASODILATATION;

EID: 0033870439     PISSN: 0194911X     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.HYP.36.2.270     Document Type: Article

References (25)

1. Hyperpolarizing factors
2. 2+ influx
3. A transferable, β-naphthoflavone-inducible, hyperpolarizing factor is synthesised by native and cultured porcine coronary endothelial cells
4. Charybdotoxin and apamin block EDHF in rat mesenteric artery if selectively applied to the endothelium
5. Endothelium-derived bradykinin is responsible for the increase in calcium produced by angiotensin-converting enzyme inhibitors in human endothelial cells
6. Nitric oxide attenuates the release of endothelium-derived hyperpolarizing factor
7. Simultaneous analysis of 4- and 5-series lipoxygenase and cytochrome P450 products from different biological sources by reversed-phase high-performance liquid chromatographic technique
8. Cytochrome P450 2C is an EDHF synthase in coronary arteries
9. Interaction of sulfaphenazole derivatives with human liver cytochromes P450 2C: Molecular origin of the specific inhibitory effects of sulfaphenazole on CYP 2C9 and consequences for the substrate binding site topology of CYP 2C9
10. Calcium antagonists ameliorate ischemia-induced endothelial permeability by inhibiting protein kinase C
11. + channels
12. Characterization of endothelium-derived hyperpolarizing factor as a cytochrome P450-derived arachidonic acid metabolite in mammals
13. Epoxyeicosatrienoic acids and dihydroxyeicosatrienoic acids are potent vasodilators in the canine coronary microcirculation
14. Display of the characteristics of endothelium-derived hyperpolarizing factor by a cytochrome P450-derived arachidonic acid metabolite in the coronary microcirculation
15. Human umbilical vein endothelial cells express P450 2C8 mRNA: Cloning of endothelial P450 epoxygenase
16. Anti-inflammatory properties of cytochrome P450 epoxygenase-derived eicosanoids
17. Characterization of rat and human liver microsomal cytochrome P-450 forms involved in nifedipine oxidation, a prototype for genetic polymorphism in oxidative drug metabolism
18. Gene structure of CYP3A4, An adult-specific form of cytochrome P450 in human livers, and its transcriptional control
19. Inhibitors of the cytochrome P450-mono-oxygenase and endothelium-dependent hyperpolarizations in the guinea-pig isolated carotid artery
20. Effects of cytochrome P450 inhibitors on EDHF-mediated relaxation in the rat hepatic artery
21. 450 mono-oxygenase
22. Substance P and bradykinin activate different types of K(ca) currents to hyperpolarize cultured porcine coronary artery endothelial cells
23. In vivo location and mechanism of EDHF-mediated vasodilation in canine coronary microcirculation
24. +-channel activity
25. + channel on pig coronary artery endothelial cells